<DOC>
	<DOCNO>NCT02822534</DOCNO>
	<brief_summary>SP2086 novel inhibitor Dipeptide base peptidase 4 , allow insulin-independent approach improve type 2 diabetes hyperglycemia . In single-dose multiple-dose study investigator evaluate safety , tolerability PK/PD profile SP2086 Type 2 Diabetes Patients .</brief_summary>
	<brief_title>The Pharmacokinetics Pharmacodynamics Study Single Multiple Dose SP2086 Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>The patient definitive diagnosis Type 2 Diabetes . BMI ( measure person 's weight relation height ) 19 30 kg/m2 , weight equal great 50kg . Never use antidiabetic use one type oral antidiabetic ( except insulin secretagogues agent ) . The patient never use insulin 3 month screen . Be willing accept physical contraception . Sign inform consent voluntarily ensure complete study . The value fast bloodglucose ( FBG ) &gt; 13.9mmol/L , HbA1c &gt; 10.0 % ; Known allergy SP2086 excipients formulation SP2086 ; Type 1 diabetes , Gestational diabetes , type diabetes ; ever occur acute complication diabetes diabetic ketoacidosis , high permeability syndrome lactic acidosis . ever occur severe hypoglycemia . History chronic complication diabetes ( kidney disease , retinopathy , neuropathy , low limb vascular lesion ) . The value serum creatinine upper limit normal range . ever occur myocardial infarction , acute coronary syndrome , transient ischemic attack . QTc interval＞450ms ( male ) ＞470ms ( female ) history cardiac insufficiency NYHA ( New York Heart Association ) class I degree . history hypertension , well control : SBP ( Systolic Blood Pressure ) &gt; 140 mmHg DBP ( Diastolic Blood Pressure ) &gt; 90 mmHg . history cancer . value ALT and/or AST great two time upper limit normal range , STB 1.5 time upper limit normal range . B hepatitis surface antigen hepatitis C antibody syphilis antibody HIV antibody positive . participate three clinical trial one year participate one time clinical medicine one month screening . history blood donation 3 month screen receive blood transfusion 1 month screen . history tobacco , alcohol drug abuse . History current clinically significant medical illness determine Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>